$ARIA News Six stocks to watch 3:27 p.m. Feb.
Post# of 144414
Six stocks to watch 3:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
'Fast Money' Recap: Should You Buy European or U.S. Stocks? 5:00 a.m. Today - TheStreet.com
Can Radius Health (RDUS) Surprise This Earnings Season? - Analyst Blog 10:06 a.m. Feb. 13, 2015 - Zacks.com
Hottest Healthcare Stocks Now – GSK ARIA CNMD SLXP 5:30 a.m. Feb. 13, 2015 - InvestorPlace.com
Will Immune Design (IMDZ) Miss on Earnings This Season? - Analyst Blog 2:40 p.m. Feb. 10, 2015 - Zacks.com
Will Ligand Pharmaceuticals (LGND) Miss on Earnings in Q4? - Analyst Blog 9:54 a.m. Feb. 6, 2015 - Zacks.com
Will Pacific Biosciences (PACB) Surprise on Earnings in Q4? - Analyst Blog 4:40 p.m. Feb. 2, 2015 - Zacks.com
Will GW Pharmaceuticals (GWPH) Miss this Earnings Season? - Analyst Blog 2:40 p.m. Feb. 2, 2015 - Zacks.com
3 Biotechs Looking Good this Earnings Season - Earnings ESP 12:38 p.m. Jan. 30, 2015 - Zacks.com
ARIAD: The Worst May Not Be Over 11:15 a.m. Jan. 28, 2015 - Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Flagged As Strong On High Volume 10:01 a.m. Jan. 28, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ABMD ARIA WOOF MNKD 5:45 a.m. Jan. 28, 2015 - InvestorPlace.com
InsiderInsights.com Daily Round Up 1/26/15: THRM, FXCM, OPK, TCBI 4:00 a.m. Jan. 28, 2015 - Seeking Alpha
10 Biotechnology Stocks to Sell Now 3:45 a.m. Jan. 28, 2015 - InvestorPlace.com
Earnings Peek: ARIAD Should Easily Beat Outdated Estimates 2:19 p.m. Jan. 27, 2015 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ARIA MYGN NVS MNKD 5:30 a.m. Jan. 27, 2015 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – LCI HCA MNKD INCY 5:45 a.m. Jan. 26, 2015 - InvestorPlace.com
Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More 4:00 p.m. Jan. 23, 2015 - Seeking Alpha
ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog 2:00 p.m. Jan. 21, 2015 - Zacks.com
ARIAD Pharmaceuticals: Is The Ship Turning Around? 11:07 a.m. Jan. 21, 2015 - Seeking Alpha
Hottest Healthcare Stocks Now – NVO CLDX ZLTQ ARIA 5:15 a.m. Jan. 20, 2015 - InvestorPlace.com
What's New in the Pharma Sector: New Research on Amgen, Applied Genetic Technologies, Aptose, ARIAD, and Atara Biotherapeutics 7:40 a.m. Feb. 13, 2015 - PR Newswire - PRF
ARIAD to Present at the RBC Capital Markets’ Healthcare Conference 7:35 a.m. Feb. 11, 2015 - BusinessWire - BZX
Critical Alerts For LinkedIn, Ariad Pharmaceuticals, Tableau Software, Nu Skin Enterprises and CBS Released By InvestorsObserver 9:31 a.m. Feb. 6, 2015 - PR Newswire - PRF
Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics 9:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
ARIAD to Present at the Leerink Global Healthcare Conference 7:35 a.m. Feb. 3, 2015 - BusinessWire - BZX
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2014 Financial Results 7:35 a.m. Jan. 29, 2015 - BusinessWire - BZX
Insider Trading Alerts for FXCM, Achillion Pharmaceuticals, Ariad Pharmaceuticals, Kinder Morgan, Twitter, and Yahoo 8:45 a.m. Jan. 27, 2015 - PR Newswire - PRF
Insider Trading Research for Delta Air Lines, Ariad Pharmaceuticals, Alcoa, Avon, FXCM, and Apple 8:45 a.m. Jan. 23, 2015 - PR Newswire - PRF
ARIAD Announces Appointment of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, as Chief Legal and Administrative Officer 7:35 a.m. Jan. 22, 2015 - BusinessWire - BZX
ARIAD Announces Final Decision from European Commission Endorsing Iclusig’s Approved Indications Throughout Europe 7:35 a.m. Jan. 20, 2015 - BusinessWire - BZX
ARIAD Announces Key Strategic Objectives for 2015 Expected to Lead Company to Profitability in Three Years 7:35 a.m. Jan. 13, 2015 - BusinessWire - BZX
ARIAD Announces Phase 2 Dose-Ranging Trial of Iclusig (Ponatinib) to Begin by Mid-2015 7:35 a.m. Jan. 6, 2015 - BusinessWire - BZX
Striking Deals on Street: New Research on State Investors, NCI, Ariad, Under Armour and Meadowbrook 9:20 a.m. Dec. 31, 2014 - PR Newswire - PRF
ARIAD Announces Commercialization Agreement for Iclusig in Seven Central and Eastern European Countries 7:35 a.m. Dec. 30, 2014 - BusinessWire - BZX
ARIAD To Present at The 33rd Annual J.P. Morgan Healthcare Conference 7:35 a.m. Dec. 22, 2014 - BusinessWire - BZX
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma 9:15 a.m. Dec. 18, 2014 - PR Newswire - PRF
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial 7:35 a.m. Dec. 8, 2014 - BusinessWire - BZX
Insider Trading Alerts for Hertz, Ariad Pharmaceuticals, J C Penney, Sirius XM, Apple, and Sunedison 8:45 a.m. Nov. 25, 2014 - PR Newswire - PRF
ARIAD and STA Announce Approval of Iclusig (Ponatinib) in Australia 7:35 a.m. Nov. 24, 2014 - BusinessWire - BZX
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF